19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Malaria parasite DNA-harbouring vesicles activate cytosolic immune sensors

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          STING is an innate immune cytosolic adaptor for DNA sensors that engage malaria parasite ( Plasmodium falciparum) or other pathogen DNA. As P. falciparum infects red blood cells and not leukocytes, how parasite DNA reaches such host cytosolic DNA sensors in immune cells is unclear. Here we show that malaria parasites inside red blood cells can engage host cytosolic innate immune cell receptors from a distance by secreting extracellular vesicles (EV) containing parasitic small RNA and genomic DNA. Upon internalization of DNA-harboring EVs by human monocytes, P. falciparum DNA is released within the host cell cytosol, leading to STING-dependent DNA sensing. STING subsequently activates the kinase TBK1, which phosphorylates the transcription factor IRF3, causing IRF3 to translocate to the nucleus and induce STING-dependent gene expression. This DNA-sensing pathway may be an important decoy mechanism to promote P. falciparum virulence and thereby may affect future strategies to treat malaria.

          Abstract

          STING is an intracellular DNA sensor that can alter response to infection, but in the case of malaria it is unclear how parasite DNA in red blood cells (RBCs) reaches DNA sensors in immune cells. Here the authors show that STING in human monocytes can sense P. falciparum nucleic acids transported from infected RBCs via parasite extracellular vesicles.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer.

          Exosomes are small vesicles (50-150 nm) of endocytic origin that are released by many different cell types. Exosomes in the tumor microenvironment may play a key role in facilitating cell-cell communication. Exosomes are reported to predominantly contain RNA and proteins. In this study, we investigated whether exosomes from pancreatic cancer cells and serum from patients with pancreatic ductal adenocarcinoma contain genomic DNA. Our results provide evidence that exosomes contain >10-kb fragments of double-stranded genomic DNA. Mutations in KRAS and p53 can be detected using genomic DNA from exosomes derived from pancreatic cancer cell lines and serum from patients with pancreatic cancer. In addition, using whole genome sequencing, we demonstrate that serum exosomes from patients with pancreatic cancer contain genomic DNA spanning all chromosomes. These results indicate that serum-derived exosomes can be used to determine genomic DNA mutations for cancer prediction, treatment, and therapy resistance.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Astrocytes and Glioblastoma cells release exosomes carrying mtDNA.

            Cells can exchange information not only by means of chemical and/or electrical signals, but also via microvesicles released into the intercellular space. The present paper, for the first time, provides evidence that Glioblastoma and Astrocyte cells release microvesicles, which carry mitochondrial DNA (mtDNA). These microvesicles have been characterised as exosomes in view of the presence of some protein markers of exosomes, such as Tsg101, CD9 and Alix. Thus, the important finding has been obtained that bonafide exosomes, constitutively released by Glioblastoma cells and Astrocytes, can carry mtDNA, which can be, therefore, transferred between cells. This datum may help the understanding of some diseases due to mitochondrial alterations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Exosomes as intercellular signalosomes and pharmacological effectors.

              Cell secretion is a general process involved in various biological responses. Exosomes are part of this process and have gained considerable scientific interest in the past five years. Several steps through investigations across the last 20 years can explain this interest. First characterized during reticulocyte maturation, they were next evidenced as a key player in the immune response and cancer immunotherapy. More recently they were reported as vectors of mRNAs, miRNAs and also lipid mediators able to act on target cells. They are the only type of vesicles released from an intracellular compartment from cells in viable conditions. They appear as a vectorized signaling system operating from inside a donor cell towards either the periphery, the cytosol, or possibly to the nucleus of target cells. Exosomes from normal cells trigger positive effects, whereas those from pathological ones, such as tumor cells or infected ones may trigger non-positive health effects. Therefore regulating the biogenesis and secretion of exosomes appear as a pharmacological challenge to intervene in various pathophysiologies. Exosome biogenesis and molecular content, interaction with target cells, utilisation as biomarkers, and functional effects in various pathophysiologies are considered in this review. Copyright © 2011 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                agbowie@tcd.ie
                neta.regev-rudzki@weizmann.ac.il
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                7 December 2017
                7 December 2017
                2017
                : 8
                : 1985
                Affiliations
                [1 ]GRID grid.1042.7, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, ; Parkville, VIC 3052 Australia
                [2 ]ISNI 0000 0001 2179 088X, GRID grid.1008.9, Department of Medical Biology, The University of Melbourne, Grattan Street, ; Parkville, VIC 3010 Australia
                [3 ]ISNI 0000 0004 0604 7563, GRID grid.13992.30, Department of Biomolecular Sciences, , Weizmann Institute of Science, ; Rehovot, 76100 Israel
                [4 ]ISNI 0000 0001 2179 088X, GRID grid.1008.9, Department of Biochemistry and Molecular Biology, , Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, ; Melbourne, VIC 3010 Australia
                [5 ]ISNI 0000 0001 2342 0938, GRID grid.1018.8, Department of Biochemistry and Genetics, , La Trobe Institute for Molecular Science, La Trobe University, ; Melbourne, 3086 VIC Australia
                [6 ]ISNI 0000 0004 1936 9705, GRID grid.8217.c, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, ; Dublin, Ireland
                [7 ]ISNI 0000 0001 2107 2845, GRID grid.413795.d, The Institute of Geographic Medicine & Tropical Diseases and The laboratory for Tropical Diseases Research, Sheba Medical Center, ; Tel Hashomer, 52621 Israel
                [8 ]ISNI 0000 0004 1937 0546, GRID grid.12136.37, Faculty of Medicine, Sackler School of Medicine, Tel Aviv University, ; Tel Aviv, 69978 Israel
                [9 ]ISNI 0000 0004 0474 1797, GRID grid.1011.1, Australian Institute of Tropical Health and Medicine, James Cook University, ; Townsville, QLD 4811 Australia
                [10 ]ISNI 0000 0004 0604 7563, GRID grid.13992.30, Flow Cytometry unit, Life Sciences Core Facilities, Weizmann Institute of Science, ; Rehovot, 76100 Israel
                [11 ]ISNI 0000 0004 1937 0546, GRID grid.12136.37, Department of Clinical Microbiology and Immunology, , Sackler Faculty of Medicine, Tel Aviv University, ; Tel Aviv, 69978 Israel
                Author information
                http://orcid.org/0000-0002-8396-1354
                http://orcid.org/0000-0003-1561-0074
                http://orcid.org/0000-0002-1102-8506
                http://orcid.org/0000-0001-9518-1833
                http://orcid.org/0000-0001-5581-2354
                Article
                2083
                10.1038/s41467-017-02083-1
                5719353
                29215015
                d475a8df-48a3-4021-a965-7f52f0f8112b
                © The Author(s) 2017

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 14 June 2017
                : 6 November 2017
                Categories
                Article
                Custom metadata
                © The Author(s) 2017

                Uncategorized
                Uncategorized

                Comments

                Comment on this article